Skip to main content
. 2021 Oct 13;12:5967. doi: 10.1038/s41467-021-26215-w

Table 1.

Demographics and clinical characteristics of the study cohorts.

Cohorts VMET VMET2
Demographics sPTB Term Total P value iPTB sPTB Term Total P value
Subject, n 29 (18%) 131 (82%) 160 3 (1%) 41 (20%) 161 (79%) 205
Sample, n 79 376 455 9 105 459 573
Mean maternal age, years ± SD (range) 32.2 ± 6.4 (20–43) 22.7 ± 7.0 (8.7–36.7) 22.5 ± 7.0 (8.7–36.7) p = 0.17 38.0 ± 3.1 (34.0–41.0) 32.7 ± 5.9 (20.0–44.0) 33.2 ± 4.7 (20–43) 33.3 ± 4.9 (20–44) p = 0.50
Mean sample gestation, weeks (±SD range) 21.8 ± 6.8 (11.7–34.3) 33.0 ± 5.0 (19–49) 32.9 ± 5.2 (19–49) p = 0.15 23.4 ± 7.2 (15.3–34.5) 21.5 ± 6.4 (12.2–32.6) 22.4 ± 6.8 (11.0–35.6) 22.3 ± 6.8 (10.5–36) p = 0.12
Mean BMI, kg/m2 (±SD, range) 26.2 ± 4.4 (18–36) 24.2 ± 4.4 (18–48) 24.5 ± 4.5 (18–48) p = 0.0002 28.9 ± 3.5 (24.0–32.0) 25.5 ± 5.6 (20.0–46.1) 25.3 ± 5.1 (18.1–39.9) 25.3 ± 5.1 (18.1–46.1) p = 0.19
Ethnicity, n/N (%)
 Caucasian 17/113 (15%) 96/113 (85%) 113/160 (71%) p = 0.14 2/130 (2%) 20/130 (15%) 108/130 (73%) 130/205 (63%) p = 0.66
 Asian 1/11 (9%) 10/11 (91%) 11/160 (7%) 0/28 (0%) 8/28 (29%) 20/28 (71%) 28/205 (14%)
 Black 11/35 (31%) 24/35 (69%) 35/160 (22%) 1/35 (3%) 10/35 (29%) 24/35 (69%) 35/205 (17%)
 Others 0/0 (0%) 0/0 (0%) 0/160 (0%) 0/12 (0%) 3/12 (25%) 9/12 (75%) 12/205 (6%)
 Not recorded* 0/1 (0%) 1/1 (100%) 1/160 (0%) 0/0 (0%) 0/0 (0%) 0/0 (0%) 0/205 (0%)
Gravida
 0 2/50 (4%) 48/50 (96%) 50/160 (31%) p = 0.01 0/1 (0%) 1/1 (100%) 0/1 (0%) 1/205 (0%) p = 0.21
 1 8/34 (24%) 26/34 (76%) 34/160 (21%) 0/45 (0%) 5/45 (11%) 40/45 (89%) 45/205 (22%)
 2 5/26 (19%) 21/26 (81%) 26/160 (17%) 1/59 (2%) 15/59 (25%) 43/59 (73%) 59/205 (29%)
 >3 14/50 (28%) 36/50 (72%) 50/160 (31%) 2/100 (2%) 20/100 (20%) 78/100 (78%) 100/205 (49%)
Previous mid trimester loss/PTB
 No 7/93 (8%) 86/93 (92%) 93/160 (58%) p = 0.00004 1/86 (1%) 7/86 (8%) 78/86 (91%) 86/205 (42%) p = 0.001
 Yes 22/67 (33%) 45/67 (67%) 67/160 (42%) 2/119 (2%) 34/119 (29%) 83/119 (70%) 119/205 (58%)
Previous excisional cervical treatment
 No 24/147 (16%) 123/147 (84%) 147/160 (92%) p = 0.045 0/105 (0%) 15/105 (14%) 90/105 (86%) 105/205 (51%) p = 0.029
 Yes 5/13 (38%) 8/13 (62%) 13/160 (8%) 1/100 (1%) 28/100 (28%) 71/100 (71%) 100//205 (49%)
Cervical cerclage material intervention
 Braided 10/45 (22%) 35/45 (78%) 45/160 (28%) p = 0.22 1/26 (4%) 13/26 (50%) 12/26 (46%) 26/205 (13%) p = 0.0007
 Monofilament 7/23 (30%) 16/23 (70%) 23/160 (14%) 0/30 (0%) 8/30 (27%) 22/30 (73%) 30/205 (15%)
 Abdominal 0/0 (0%) 0/0 (0%) 0/160 (0%) 0/2 (0%) 0/2 (0%) 2/2 (100%) 2/205 (1%)
 No intervention 12/92 (13%) 80/92 (87%) 92/160 (58%) 2/142 (1%) 18/142 (13%) 122/142 (86%) 142/205 (69%)
 Not recorded* 0/0 (0%) 0/0 (0%) 0/160 (0%) 0/5 (0%) 2/5 (40%) 3/5 (60%) 5/205 (2%)

sPTB spontaneous preterm birth, iPTB  iatrogenic preterm birth. Comparisons of means between sPTB and Term group were done using two-sided Student’s t-tests for continuous covariates (maternal age, sample gestation and BMI), and two-sided Pearson’s chi-squared tests were used to compare the distribution of categorical variables (ethnicity, gravida, previous mid trimester loss/PTB, previous excisional cervical treatment, cervical cerclage material intervention).